ZEJULA

Identification of Zejula

No description

Google image searchProduct monograph

Active ingredient

niraparib (niraparib tosylate), 100 MG

DIN: 02530031

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: GLAXOSMITHKLINE INC

Date: 13-SEP-2023

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
• L01XK — Poly (ADP-ribose) polymerase (PARP) inhibitors (ATC, ATC/DDD)
• L01XK02 — NIRAPARIB (ATC/DDD)

External Links for Zejula

Search on Google

• Zejula side effects
• Zejula dosage
• niraparib side effects
• niraparib dosage

Glaxosmithkline Inc

Go to GlaxoSmithKline website to see drug product details. Sometimes you can find zejula photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.